These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8454114)

  • 1. Transcription factor jun-B is target of autoreactive T-cells in IDDM.
    Honeyman MC; Cram DS; Harrison LC
    Diabetes; 1993 Apr; 42(4):626-30. PubMed ID: 8454114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A 64 kDa antigen/glutamic acid decarboxylase (GAD) in fetal pig pro-islets: co-precipitation with a 38 kDa protein and recognition by T cells in humans at risk for insulin-dependent diabetes.
    DeAizpurua HJ; Honeyman MC; Harrison LC
    J Autoimmun; 1992 Dec; 5(6):759-70. PubMed ID: 1489487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular immune response to diverse islet cell antigens in IDDM.
    Durinovic-Bellò I; Hummel M; Ziegler AG
    Diabetes; 1996 Jun; 45(6):795-800. PubMed ID: 8635655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High T cell responses to the glutamic acid decarboxylase (GAD) isoform 67 reflect a hyperimmune state that precedes the onset of insulin-dependent diabetes.
    Honeyman MC; Stone N; de Aizpurua H; Rowley MJ; Harrison LC
    J Autoimmun; 1997 Apr; 10(2):165-73. PubMed ID: 9185878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of CD8+ T lymphocytes in insulin-dependent diabetes mellitus.
    Togun RA; Resetkova E; Kawai K; Enomoto T; Volpé R
    Clin Immunol Immunopathol; 1997 Mar; 82(3):243-9. PubMed ID: 9073547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Similar peptides from two beta cell autoantigens, proinsulin and glutamic acid decarboxylase, stimulate T cells of individuals at risk for insulin-dependent diabetes.
    Rudy G; Stone N; Harrison LC; Colman PG; McNair P; Brusic V; French MB; Honeyman MC; Tait B; Lew AM
    Mol Med; 1995 Sep; 1(6):625-33. PubMed ID: 8529129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The 37/40-kilodalton autoantigen in insulin-dependent diabetes mellitus is the putative tyrosine phosphatase IA-2.
    Passini N; Larigan JD; Genovese S; Appella E; Sinigaglia F; Rogge L
    Proc Natl Acad Sci U S A; 1995 Sep; 92(20):9412-6. PubMed ID: 7568143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoimmune disorders in diabetes.
    Boitard C; Debray-Sachs M; Bach JF
    Adv Nephrol Necker Hosp; 1986; 15():281-305. PubMed ID: 3082114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-islet cell and anti-insulin antibody production by CD5+ and CD5- B lymphocytes in IDDM.
    Muñoz A; Gallart T; Usac EF; Fernández-Alvarez J; Viñas O; Somoza N; Barceló J; Gomis R
    Diabetologia; 1995 Jan; 38(1):62-72. PubMed ID: 7538087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pancreatic islet cell cytoplasmic antibody in diabetes is represented by antibodies to islet cell antigen 512 and glutamic acid decarboxylase.
    Myers MA; Rabin DU; Rowley MJ
    Diabetes; 1995 Nov; 44(11):1290-5. PubMed ID: 7589826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of GAD65 antibodies in diabetes and other autoimmune diseases using a simple radioligand assay.
    Petersen JS; Hejnaes KR; Moody A; Karlsen AE; Marshall MO; Høier-Madsen M; Boel E; Michelsen BK; Dyrberg T
    Diabetes; 1994 Mar; 43(3):459-67. PubMed ID: 8314020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Islet-reactive T cells are a marker of preclinical insulin-dependent diabetes.
    Harrison LC; Chu SX; DeAizpurua HJ; Graham M; Honeyman MC; Colman PG
    J Clin Invest; 1992 Apr; 89(4):1161-5. PubMed ID: 1556180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered immune response to insulin in newly diagnosed compared to insulin-treated diabetic patients and healthy control subjects.
    Schloot NC; Roep BO; Wegmann D; Yu L; Chase HP; Wang T; Eisenbarth GS
    Diabetologia; 1997 May; 40(5):564-72. PubMed ID: 9165225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human B cells secreting immunoglobulin G to glutamic acid decarboxylase-65 from a nondiabetic patient with multiple autoantibodies and Graves' disease: a comparison with those present in type 1 diabetes.
    Tremble J; Morgenthaler NG; Vlug A; Powers AC; Christie MR; Scherbaum WA; Banga JP
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2664-70. PubMed ID: 9253351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA-associated inverse correlation between T cell and antibody responsiveness to islet autoantigen in recent-onset insulin-dependent diabetes mellitus.
    Roep BO; Duinkerken G; Schreuder GM; Kolb H; de Vries RR; Martin S
    Eur J Immunol; 1996 Jun; 26(6):1285-9. PubMed ID: 8647206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytoplasmic islet cell antibodies recognize distinct islet antigens in IDDM but not in stiff man syndrome.
    Richter W; Seissler J; Northemann W; Wolfahrt S; Meinck HM; Scherbaum WA
    Diabetes; 1993 Nov; 42(11):1642-8. PubMed ID: 8405707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined analysis and single-step detection of GAD65 and IA2 autoantibodies in IDDM can replace the histochemical islet cell antibody test.
    Wiest-Ladenburger U; Hartmann R; Hartmann U; Berling K; Böhm BO; Richter W
    Diabetes; 1997 Apr; 46(4):565-71. PubMed ID: 9075795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoantigens in insulin-dependent diabetes mellitus: molecular cloning and characterization of human IA-2 beta.
    Li Q; Borovitskaya AE; DeSilva MG; Wasserfall C; Maclaren NK; Notkins AL; Lan MS
    Proc Assoc Am Physicians; 1997 Jul; 109(4):429-39. PubMed ID: 9220540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoantibodies to the islet antigen ICA69 occur in IDDM and in rheumatoid arthritis.
    Martin S; Kardorf J; Schulte B; Lampeter EF; Gries FA; Melchers I; Wagner R; Bertrams J; Roep BO; Pfützner A
    Diabetologia; 1995 Mar; 38(3):351-5. PubMed ID: 7758883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validity of screening for individuals at risk for type I diabetes by combined analysis of antibodies to recombinant proteins.
    Christie MR; Roll U; Payton MA; Hatfield EC; Ziegler AG
    Diabetes Care; 1997 Jun; 20(6):965-70. PubMed ID: 9167107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.